Overview

Description

  • Nature
    Synthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab25719 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-Fatty Acid Synthase antibody (ab22759)

  • Form
    Liquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • [Acyl-carrier-protein] S acetyltransferase
    • [Acyl-carrier-protein] S malonyltransferase
    • 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase
    • 3-oxoacyl-[acyl-carrier-protein] reductase
    • 3-oxoacyl-[acyl-carrier-protein] synthase
    • Enoyl-[acyl-carrier-protein] reductase
    • FAS
    • FAS_HUMAN
    • FASN
    • Fatty acid synthase
    • MGC14367
    • MGC15706
    • OA 519
    • Oleoyl-[acyl-carrier-protein] hydrolase
    • SDR27X1
    • Short chain dehydrogenase/reductase family 27X member 1
    see all
  • Function
    Fatty acid synthetase catalyzes the formation of long-chain fatty acids from acetyl-CoA, malonyl-CoA and NADPH. This multifunctional protein has 7 catalytic activities and an acyl carrier protein.
  • Tissue specificity
    Ubiquitous. Prominent expression in brain, lung, and liver.
  • Sequence similarities
    Contains 1 acyl carrier domain.
  • Cellular localization
    Cytoplasm. Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
  • Information by UniProt

References

This product has been referenced in:
  • Greseth MD & Traktman P De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog 10:e1004021 (2014). Read more (PubMed: 24651651) »

See 1 Publication for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab25719.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up